USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration

Figure 2

Six datasets were recruited to confirm the differential expression of six-USPs in pancreatic ductal adenocarcinoma (PDAC). (a) The mRNA levels of six-USPs via the comparison between PDAC () and normal pancreatic tissues () in GSE16515 dataset. (b)The expression levels of six-USPs in PDAC tissues () compared with normal tissues () in GSE62165 dataset. (c) The mRNA levels of six-USPs via the comparison between PDAC () and normal pancreatic tissues () in GSE101448 dataset. (d) The expression levels of six-USPs in PDAC tissues () versus adjacent noncancerous tissues (ANCT) () in GSE62452 dataset. (e) The transcriptional levels of six-USPs in PDAC tissues compared with ANCT ( pairs) in GSE28735 dataset. (f) The expression levels of six-USPs in PDAC tissues compared with ANCT () in GSE15471 dataset. The code behind the gene is the gene ID in different GEO datasets. , , , and .

(a)

(b)

(c)

(d)

(e)

(f)